Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study

BMC Endocrine Disorders

Table 1 Correlations between anthropometric measures and metabolic markers in women with polycystic ovary syndrome

	%ASM	%BFLTM	%FM	BMI	WC
hsCRP	−0.608**	−0.755**	0.733**	0.571**	0.628**
HOMA	−0.409*	−0.502**	0.520**	0.575**	0.581**
Vitamin D (25-OH)	0.398*	0.430**	−0.430**	−0.374*	−0.379*
HbA1C	−0.430**	−0.538**	0.532**	0.479**	0.410*

Correlation coefficient and p values determined using Spearman correlations. (*) represents significant correlation, p < 0.01, (**) represents significant correlation, p < 0.0001. % ASM, % appendicular skeletal muscle mass; % BFLTM, % bone-free lean tissue mass; % FM, % fat mass; BMI, body mass index; HbA1C, glycosylated hemoglobin; HOMA, homeostasis model assessment insulin resistance index hsCRP, high sensitive C-reactive protein; WC, waist circumference

ISSN: 1472-6823